These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 951885)

  • 1. Successful use of a totally heparin grafted hemodialysis system in sheep.
    Schmer G; Teng LN; Cole JJ; Vizzo JE; Francisco MM; Scribner BH
    Trans Am Soc Artif Intern Organs; 1976; 22():654-63. PubMed ID: 951885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hollow fiber artificial kidney (hfak) dialysis without parenteral heparin.
    Schmer G; Kelly M; Cole J; Vizzo J; Scribner BH
    Proc Clin Dial Transplant Forum; 1973; 3():46-51. PubMed ID: 4808074
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane B2 blood levels and incipient system clotting in heparin free hemodialysis.
    Keller F; Hericks K; Schuller I; Passfall J; Joerres A; Meinhold H
    ASAIO J; 1995; 41(2):173-7. PubMed ID: 7640422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-free hemodialysis with Cuprophan hollow fiber dialyzers by a frequent saline flush, high blood flow technique.
    Agresti J; Conroy JD; Olshan A; Conroy JF; Schwartz A; Brodsky I; Krevolin L; Chinitz J
    Trans Am Soc Artif Intern Organs; 1985; 31():590-4. PubMed ID: 3837514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grafted synthetic sorbents for enhanced removal of toxic chemical agents from plasma.
    McPhillips DM; Armer TA; Owen DR
    J Biomed Mater Res; 1983 Nov; 17(6):993-1002. PubMed ID: 6654935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin free dialysis: comparative data and results in high risk patients.
    Caruana RJ; Raja RM; Bush JV; Kramer MS; Goldstein SJ
    Kidney Int; 1987 Jun; 31(6):1351-5. PubMed ID: 3613407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ticlopidine and heparin on hemodialysis in dogs.
    Gross ML; Bush H; Weinger R; Hamburger RJ; Flamenbaum W
    J Lab Clin Med; 1982 Dec; 100(6):887-95. PubMed ID: 7142790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
    van Wyk V; Badenhorst PN; Kotzé HF
    Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uremic tendencies for hemorrhage and hemodialysis].
    Vogel GE; Hansen W; Goldmann FL; Kopp KF
    Z Urol Nephrol; 1977 Dec; 70(12):895-900. PubMed ID: 607692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with the capillary dialysator (HFAK 4). 1. In-vivo measurements on pressure behavior, blood perfusion and ultrafiltration during multiple use].
    Thieler H; Marx M; Schmidt U; Giertler R
    Z Urol Nephrol; 1975 Dec; 68(12):895-901. PubMed ID: 132061
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-free hemodialysis with prophylactic change of dialyser and blood lines.
    Preuschof L; Keller F; Seemann J; Offermann G
    Int J Artif Organs; 1988 Jul; 11(4):255-8. PubMed ID: 3410566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of hemodialyzers' designs.
    Twardowski ZJ
    Hemodial Int; 2008 Apr; 12(2):173-210. PubMed ID: 18394051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a new antithrombotic (dermatan sulfate) in chronic hemodialysis patients.
    Nurmohamed MT; Knipscheer HC; Stevens P; Krediet RT; Roggekamp MC; Berckmans RJ; ten Cate JW
    Clin Nephrol; 1993 Mar; 39(3):166-71. PubMed ID: 8462205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombogenic cellulose membranes for blood dialysis.
    Merrill EW; Salzman EW; Lipps BJ; Gilliland ER; Austen WG; Joison J
    Trans Am Soc Artif Intern Organs; 1966; 12():139-50. PubMed ID: 5960693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method for the repeated use of Cordis Dow (model 4) capillary dialyers].
    Kozlechkov IuA; Overchenko AV
    Urol Nefrol (Mosk); 1978; (2):65. PubMed ID: 347668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.